Boxer Capital, LLC Protara Therapeutics, Inc. Transaction History
Boxer Capital, LLC
- $1.88 Billion
- Q3 2024
A detailed history of Boxer Capital, LLC transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Boxer Capital, LLC holds 811,627 shares of TARA stock, worth $1.86 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
811,627
Previous 811,627
-0.0%
Holding current value
$1.86 Million
Previous $1.69 Million
12.03%
% of portfolio
0.08%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding TARA
# of Institutions
39Shares Held
10.7MCall Options Held
9KPut Options Held
1.8K-
Ra Capital Management, L.P. Boston, MA1.9MShares$4.35 Million0.05% of portfolio
-
Opaleye Management Inc. Boston, MA1.68MShares$3.85 Million0.56% of portfolio
-
Stem Point Capital LP New York, NY943KShares$2.16 Million0.52% of portfolio
-
Woodline Partners LP San Francisco, CA852KShares$1.95 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA760KShares$1.74 Million0.0% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $25.8M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...